THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS

被引:0
|
作者
Demir, Nazlim Aktug [1 ]
Dagi, Hatice Turk [2 ]
Findik, Duygu [2 ]
Sumer, Sua [1 ]
Ural, Onur [1 ]
Kolgelier, Servet [3 ]
机构
[1] Selcuk Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Alaeddin Keykubat Campus, TR-42250 Konya, Turkey
[2] Selcuk Univ, Dept Clin Microbiol, Fac Med, TR-42250 Konya, Turkey
[3] Adiyaman Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Adiyaman, Turkey
来源
NOBEL MEDICUS | 2015年 / 11卷 / 01期
关键词
Brucellosis; C-reactive protein; soluble urokinase type plasminogen activator receptor;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Brucellosis is a common zoonotic infectious disease especially in Mediterranean countries. Inflammatory markers are elevated during the course of acute brucellosis. C-reactive protein (CRP) is the most commonly used biochemical marker in clinical practice. Soluble urokinase type plasminogen activator receptor (suPAR) is an interesting biomarker which has drawn attention recently. Purpose o f this study is to examine correlation between suPAR and CRP levels as markers o f infectious disease in patients diagnosed with acute brucellosis. Material and Method: This study included 125 acute brucellosis patients and 50 healthy controls. Pretreatment blood samples were taken from the patients. suPAR levels were measured using ELISA and CRP levels were measured with nephelometry. Results: There was a positive correlation between suPAR levels and CRP, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (p=0.045, 0.039, 0.040; respectively). When we compared patient and control groups, CRP and suPAR levels were significantly higher than controls (p=0.001, 0.001; respectively). Growth in blood culture was detected in 14 (11.2%) patients. Tlrere was not a significant difference between patients who have or did not have growth in blood cultures (p=0.117). In the ROC curve analysis performed for suPAR, area under the curve (AUC) was 93.6% (p=0.001). Sensitivity and specificity were calculated as 84.8% and 86.0%, respectively, when suPAR's cut-off value was taken as 3.85 ng/mL according to the ROC curve. Conclusion: Results of this study suggest that suPAR, like CRP, is a promising biomarker in acute brucellosis.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 50 条
  • [1] Urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) serum level in patients with malignant lymphomas
    Hus, I
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    Chrapko, M
    Hus, M
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 141 - 144
  • [2] Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis
    Drechsler, Christiane
    Hayek, Salim S.
    Wei, Changli
    Sever, Sanja
    Genser, Bernd
    Krane, Vera
    Meinitzer, Andreas
    Marz, Winfried
    Wanner, Christoph
    Reiser, Jochen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (08): : 1265 - 1273
  • [3] Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain
    Lyngbaek, Stig
    Andersson, Charlotte
    Marott, Jacob L.
    Moller, Daniel V.
    Christiansen, Michael
    Iversen, Kasper K.
    Clemmensen, Peter
    Eugen-Olsen, Jesper
    Hansen, Peter R.
    Jeppesen, Jorgen L.
    CLINICAL CHEMISTRY, 2013, 59 (11) : 1621 - 1629
  • [4] Soluble urokinase plasminogen activator receptor in patients with abdominal aortic aneurysm
    Lindqvist, Markus
    Wallinder, Jonas
    Henriksson, Anders E.
    THROMBOSIS RESEARCH, 2012, 130 (03) : 511 - 513
  • [5] The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
    Erkut, Nergiz
    Mentese, Ahmet
    Ozbas, Hasan Mucahit
    Ermantas, Nilay
    Sumer, Aysegul
    Orem, Asim
    Sonmez, Mehmet
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 135 - 140
  • [6] Measurement of soluble urokinase plasminogen activator receptor in serum
    Riisbro, R
    Piironen, T
    Brünner, N
    Larsen, B
    Nielsen, HJ
    Stephens, RW
    Hoyer-Hansen, G
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (01): : 53 - 56
  • [7] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [8] Prognostic value of soluble urokinase plasminogen activator receptor (suPAR) in patients admitted with acute heart failure
    Kandiah, A.
    Taraldsen, I
    El-Sheikh, M.
    El Caidi, N. Olsen
    Wisborg, F. Dencker
    Hove, J. Dahlgaard
    Grand, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness
    Chew-Harris, J. S.
    Appleby, S.
    Richards, A. M.
    Troughton, R. W.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1573 - 1573
  • [10] SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE
    Lupusoru, Gabriela Elena
    Ailincai, Ioana-Georgiana
    Sorohan, Bogdan Marian
    Andronesi, Andreea Gabriella
    Lupusoru, Mircea
    Andronesi, Danut
    Manda, Dana
    Caragheorgheopol, Andra
    Ismail, Gener
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 378 - 378